15.21
Jade Biosciences Inc 주식(JBIO)의 최신 뉴스
Jade Biosciences secures $45 million in private placement from BB Biotech - Investing.com
Jade Biosciences Says to Raise $45 Million via Private Placement of 3.2 Million Shares - marketscreener.com
Jade Biosciences announces $45 million private placement - marketscreener.com
Jade Biosciences (Nasdaq: JBIO) sells 3.2M shares in $45M private placement - Stock Titan
Frazier Life Sciences Management L.P. Makes New $17.70 Million Investment in Jade Biosciences, Inc. $JBIO - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Trading 7.4% HigherHere's What Happened - MarketBeat
Jade Biosciences (JBIO): Analyst Lauds Entry into Market - Finviz
Jade Biosciences (JBIO): Analyst lauds entry into market - MSN
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock - MSN
The growth track for Jade Biosciences Inc (JBIO) has changed recently - setenews.com
Jade Biosciences (NASDAQ:JBIO) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Geode Capital Management LLC Purchases Shares of 676,431 Jade Biosciences, Inc. $JBIO - MarketBeat
Does Jade Biosciences, Inc. (JBIO) Have the Potential to Rally 65% as Wall Street Analysts Expect? - Zacks Investment Research
11 Best Micro-Cap Stocks to Invest in According to Analysts - Insider Monkey
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives $19.75 Average Price Target from Brokerages - Defense World
Is Jade Biosciences Inc. stock resilient to inflationWeekly Trade Analysis & Daily Growth Stock Investment Tips - BỘ NỘI VỤ
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Will Jade Biosciences Inc. stock rally after Fed decisions2025 Major Catalysts & Smart Investment Allocation Tips - BỘ NỘI VỤ
Jade Biosciences Inc (JBIO) looking to reclaim success with recent performance - Setenews
Clear Street Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq
Clear Street initiates Jade Biosciences stock with Buy rating on IgAN therapy - Investing.com Canada
How Jade Biosciences Inc. stock performs after earnings2025 Top Gainers & High Win Rate Trade Tips - newser.com
Versant Venture Management LLC Invests $15.24 Million in Jade Biosciences, Inc. $JBIO - MarketBeat
Guggenheim Maintains Jade Biosciences (JBIO) Buy Recommendation - MSN
Jade Biosciences (NASDAQ:JBIO) Price Target Raised to $17.00 at Guggenheim - MarketBeat
Detecting support and resistance levels for Jade Biosciences Inc.Short Setup & Weekly High Conviction Trade Ideas - newser.com
How Jade Biosciences Inc. stock performs during Fed tightening cyclesJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Is Jade Biosciences Inc. forming a reversal patternJuly 2025 Analyst Calls & Proven Capital Preservation Methods - newser.com
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - Zacks Investment Research
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday - Benzinga
Does Jade Biosciences Inc. fit your quant trading modelWeekly Gains Report & Reliable Volume Spike Trade Alerts - newser.com
Jade Biosciences (NASDAQ:JBIO) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Jade Biosciences Advances Autoimmune Therapies - MSN
Multi asset correlation models including Jade Biosciences Inc.Quarterly Trade Review & Reliable Entry Point Alerts - newser.com
Jade Biosciences (NASDAQ:JBIO) Posts Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat
Jade Biosciences files for offering of up to 16.1 million shares of common stock by the selling stockholdersSEC filing - MarketScreener
Wedbush Adjusts Price Target on Jade Biosciences to $19 From $18, Maintains Outperform Rating - MarketScreener
JBIO: Strong pipeline progress and financing extend cash runway into 2028 despite higher net loss - TradingView
Jade Biosciences Reports Q3 2025 Financial Results - TipRanks
Jade Biosciences, Inc. SEC 10-Q Report - TradingView
How Jade Biosciences Inc. stock reacts to inflationary pressuresSell Signal & Daily Volume Surge Trade Alerts - newser.com
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Jade Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Will Jade Biosciences Inc. see short term momentumWeekly Trend Summary & Safe Capital Growth Plans - newser.com
Jade Biosciences (JBIO) Price Target Increased by 13.43% to 19.38 - MSN
자본화:
|
볼륨(24시간):